| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5817028 | ARNA PHARMA | Method and device for the provocation of air passage narrowing and/or the induction of sputum |
Feb, 2015
(9 years ago) | |
Aridol Kit is owned by Arna Pharma.
Aridol Kit contains Mannitol.
Aridol Kit has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Aridol Kit are:
- US5817028
Aridol Kit was authorised for market use on 05 October, 2010.
Aridol Kit is available in powder;inhalation dosage forms.
Aridol Kit can be used as assessment of bronchial hyperresponsiveness in patients 6 years of age or older who do not have clinically apparent asthma.
The generics of Aridol Kit are possible to be released after 23 February, 2015.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Oct 05, 2013 |
Drugs and Companies using MANNITOL ingredient
Market Authorisation Date: 05 October, 2010
Treatment: Assessment of bronchial hyperresponsiveness in patients 6 years of age or older who do not have clinically apparent asthma
Dosage: POWDER;INHALATION
ARIDOL KIT family patents
